Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Daniel Merk, Julian A. Marschner et al.|Journal of the American Chemical Society|2023Cited by 49
Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and EmpagliflozinManga Motrapu, Lidia Anguiano, Monika Świderska et al.|Journal of the American Society of Nephrology|2020Cited by 29
Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 AgonistsDaniel Zaienne, Daniel Merk, Jan Heering et al.|ChemMedChem|2022Cited by 11
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Daniel Merk, Felix Nawa et al.|Journal of Medicinal Chemistry|2023Cited by 10
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Daniel Merk, Romy Busch et al.|Journal of Medicinal Chemistry|2024Cited by 6